Concepedia

Nicholas Di Bella

ND

6

Publications

238

Citations

6

H-Index

2004

Active since

Affiliations

Texas Oncology(Current)

Rocky Mountain Cancer Centers

Cancer Care Northwest

The US Oncology Network

Nicholas Di Bella is an author at Texas Oncology specializing in pharmacotherapy, radiation oncology, and oncology.

Top concepts

Publications per year

2004–2011

6

Publications

6

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma

Nicholas Di Bella, Raymond Taetle, Kathryn S. Kolibaba et al. · Blood · 2009 · 77 citations · Full text

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons et al. · Investigational New Drugs · 2011 · 63 citations

, , +9

Results of a Phase II Multicenter Trial of Single-Agent Gemcitabine in Patients with Relapsed or Chemotherapy-Refractory Hodgkin's Lymphoma

Hemachandra Venkatesh, Nicholas Di Bella, Thomas P. Flynn et al. · Clinical Lymphoma · 2004 · 49 citations

, , +8

Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Craig H. Reynolds, Nicholas Di Bella, Roger M. Lyons et al. · Blood · 2008 · 28 citations

An open‐label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low‐grade non‐Hodgkin lymphoma

Nicholas Di Bella, Craig H. Reynolds, D Faragher et al. · Cancer · 2005 · 11 citations · Full text

Rows per page

1–5 of 6